Related Experiment Videos

Estimation of interleukin 6 production by reverse transcriptase-polymerase chain reaction in four human myeloma cell

A Suzuki1, T Takahashi, Y Okuno

  • 1Second Department of Internal Medicine, Kyoto University, Japan.

Leukemia Research
|January 1, 1991
PubMed

Insights

Interleukin 6 (IL-6) autocrine growth is unlikely in most human myeloma cell lines. Researchers found minimal IL-6 mRNA in one cell line but no detectable IL-6 protein or growth inhibition by antibodies.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Interleukin 6 (IL-6) is implicated in autocrine growth mechanisms in human myeloma cells.
  • However, evidence of IL-6 production by established myeloma cell lines is scarce.

Purpose of the Study:

  • To investigate the production of IL-6 in four human myeloma cell lines.
  • To determine if IL-6 autocrine stimulation contributes to myeloma cell proliferation.

Main Methods:

  • Enzyme immunoassay, bioassay using IL-6-dependent hybridoma cell lines, and Northern hybridization were employed to detect IL-6.
  • Reverse transcriptase-polymerase chain reaction (RT-PCR) was used to detect IL-6 mRNA.
  • The effect of an anti-IL-6 antibody on cell proliferation was assessed.

Main Results:

  • IL-6 production was undetectable in all four myeloma cell lines by immunoassay, bioassay, and Northern hybridization.
  • IL-6 mRNA was detected in one cell line (U266) via RT-PCR.
  • Anti-IL-6 antibody did not inhibit the proliferation of any of the four cell lines.

Conclusions:

  • Autocrine stimulation by IL-6 does not appear to be a significant factor in the growth of most human myeloma cell lines.
  • While IL-6 mRNA can be present, functional IL-6 protein production or its role in proliferation may be limited.

Related Concept Videos